106429-59-8

Basic information

• Product Name: 1H-Benzimidazole-5-carboxaldehyde,2,3-dihydro-2-oxo-(9CI)
• Synonyms: 1H-Benzimidazole-5-carboxaldehyde,2,3-dihydro-2-oxo-(9CI);2-oxo-2,3-dihydro-1H-benzo[d]iMidazole-5-carbaldehyde;2,3-Dihydro-2-oxo-1H-benzimidazole-5-carboxaldehyde;1H-BenziMidazole-5-carboxaldehyde, 2,3-dihydro-2-oxo-;2,3-Dihydro-2-oxo-1H-benzo[d]imidazol-5-carbaldehyde;2-OXO-2,3-DIHYDRO-1H-1,3-BENZODIAZOLE-5-CARBALDEHYDE;2-oxo-1,3-dihydrobenzimidazole-5-carbaldehyde
• CAS NO: 106429-59-8
• Molecular Formula: C₈H₆N₂O₂
• Molecular Weight: 162.14544
• Product Categories: BENZIMIDAZOLE
• Mol File: 106429-59-8.mol

Chemical Properties

• Boiling Point: 194℃
• Flash Point: 81℃
• Appearance: /
• Density: 1.365
• Storage Temp.: Sealed in dry,Room Temperature
• Solubility: DMSO (Slightly, Sonicated), Methanol (Slightly, Heated, Sonicated)
• PKA: 11.66±0.30(Predicted)
• CAS DataBase Reference: 1H-Benzimidazole-5-carboxaldehyde,2,3-dihydro-2-oxo-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Benzimidazole-5-carboxaldehyde,2,3-dihydro-2-oxo-(9CI)(106429-59-8)
• EPA Substance Registry System: 1H-Benzimidazole-5-carboxaldehyde,2,3-dihydro-2-oxo-(9CI)(106429-59-8)

Safety Data

• Hazardous Substances Data: 106429-59-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
1H-Benzimidazole-5-carboxaldehyde,2,3-dihydro-2-oxo-(9CI) is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure allows for the development of novel drugs with potential therapeutic applications.
Used in Nuclease Inhibitors:
1H-Benzimidazole-5-carboxaldehyde,2,3-dihydro-2-oxo-(9CI) is used as a precursor in the preparation of nuclease inhibitors. These inhibitors are useful in the treatment and prophylaxis of diseases where nuclease activity plays a role, such as certain types of cancer or viral infections. By inhibiting nucleases, these compounds can help regulate cellular processes and potentially prevent or slow down disease progression.

Upstream product

• 1313-13-9 manganese dioxide 
• 106429-58-7 5-hydroxymethyl-1,3-dihydro-benzoimidazol-2-one 
• 1575-37-7 4-Bromo-benzene-1,2-diamine 
• 39513-26-3 5-bromo-1,3-dihydro-benzoimidazol-2-one 
• 221289-88-9 2-oxo-2,3-dihydro-1H-benzo[d]imidazole-5-carbonitrile 
• 17626-40-3 4-cyano-1,2-phenylenediamine 
• 221289-88-9 2-hydroxybenzimidazole-5-carbonitrile 

Downstream Products

• 288579-82-8 5-formyl-2-chlorobenzimidazole 

Relevant articles and documents

POLYCYCLIC AMINES AS OPIOID RECEPTOR MODULATORS

The present invention provides a genus of polycyclic amines that are useful as opioid receptor modulators. The compounds of the invention are useful in both therapeutic and diagnostic methods, including for treating pain, neurological disorders, cardiac disorders, bowel disorders, drug and alcohol addiction, drug overdose, urinary disorders, respiratory disorders, sexual dysfunction, psoriasis, graft rejection or cancer.

INHIBITORS OF THE MENIN-MLL INTERACTION

The present invention is directed to inhibitors of the interaction of menin with MLL and MLL fusion proteins, pharmaceutical compositions containing the same, and their use in the treatment of cancer and other diseases mediated by the menin-MLL interaction.

SUBSTITUTED DIHYDROPYRIDINES AND METHODS OF USE

Compounds are provided that are modulators of the C5a receptor. The compounds are substituted dihydropyridines and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activtation of C5a receptors.

ANABASEINE DERIVATIVES USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISEASES

The compounds of the present invention are of formula (I): wherein A, R3, R4 is as defined herein, are useful as ligands for nicotinic receptors.

2'-Substituted 5-phenylterbenzimidazoles as topoisomerase I poisons

5-Phenylterbenzimidazole (1) is active as a topoisomerase I poison (topo I) and is cytotoxic to human tumor cells. No cross-resistance was observed for 1 when it was evaluated against the camptothecin-resistant cell line, CPT-K5. Derivatives of 1 substituted at the 2'-position, however, did exhibit cross-resistance to this cell line. The basis for the resistance of this cell line towards CPT is that it possesses a mutant form of topo I. These results suggest that substituents at the 2'-position may be in proximity to the wild-type enzyme. Therefore, we hypothesized that terbenzimidazoles with 2'-substituents could be capable of interacting with the enzyme and thereby influence activity within this class of topo I poisons. 5-Phenylterbenzimidazoles with a hydroxy, hydroxymethyl, mercapto, amino, N-benzoylaminomethyl, chloro, and trifluoromethyl group at the 2'-position were synthesized. In addition, several 2'-ethyl-5-phenylterbenzimidazoles were prepared containing either a methoxy, hydroxy, amino, or N-acetylamino group at the 2-position of the ethyl side-chain. These 2'-substituted 5-phenylterbenzimidazoles were evaluated as topo I poisons and for cytotoxic activity. The presence of a strong electron-withdrawing group at the 2'-position, such as a chloro or trifluoromethyl group, did enhance both topo I poisoning activity and cytotoxicity. Studies on the relative DNA binding affinity of 1 to its 2'-amino and 2'-trifluoromethyl derivatives did exhibit a correlation with their relative differences in biological activity. Copyright (C) 2000 Elsevier Science Ltd.

Heterocyclic topoisomerase poisons

The invention provides a topoisomerase poison of formula I: wherein R1-R8 have any of the meanings defined in the specification, or a pharmaceutically acceptable salt thereof, as well as pharmaceutical compositions comprising a compound of formula I or a salt thereof, intermediates useful for preparing a compound of formula I, and therapeutic methods comprising administering a compound of formula I or a salt thereof.

Topoisomerase I inhibition and cytotoxicity of 5-bromo- and 5-phenylterbenzimidazoles

Topoisomerase I is an enzyme that is essential for maintaining the three-dimensional structure of DNA during the processes of transcription, translation and mitosis. With the introduction of new clinical agents that are effective in poisoning topoisomeras

Novel β-lactam antibiotics

Antibacterially active and animal growth-promoting novel β-lactam compounds of the formula STR1 in which R1 represents the radical STR2 Y representing N or CR9, or Y--R7 representing >C=O or >C=N--R7, Z representing O, S, or NR10, and R2 represents hydrogen or a protective group.